Form 4 for CODX Co-Diagnostics, Inc.

Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-08 · accession 0001562180-23-000287 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2023-01-09	2023-01-08	CODX	SERBIN RICHARD S	Dir	A - Grant	$0.00	+12.5K	39.2K	+47%	$0
D	2023-01-09	2023-01-08	CODX	SERBIN RICHARD S	Dir	M - OptEx	$0.00	-12.5K	58.3K	-18%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-01-08	A	A	12,500	$0.00	39,167	D	—	—	(F1) Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. Included in 70,000 restricted stock units awarded to the Reporting Person on July 11, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022.
2	Derivative	Restricted Stock Units	2023-01-08	M	D	12,500	$0.00	58,333	D	$0.00 · — to —	70,833 Common Stock	(F1) Included in 37,500 restricted stock units awarded to the Reporting Person on January 8, 2021, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in three equal installments every twelve months commencing on January 8, 2021. Included in 70,000 restricted stock units awarded to the Reporting Person on July 11, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in 6 equal installments every 6 months commencing on November 23, 2022.